Unveiling the Heart’s Vulnerability: Insights into COVID-19-Induced Cardiac Damage

While it has been widely acknowledged that COVID-19 elevates the risk of heart attack, stroke, and the onset of Long COVID, the underlying mechanism behind cardiac damage remained uncertain. Previous imaging studies have indicated that over 50% of COVID-19 patients experience some degree of heart inflammation or damage. However, whether this damage arises from direct viral infection of heart tissue or systemic inflammation prompted by the body’s immune response to the virus remained a pivotal question.

To elucidate this, researchers turned their attention to cardiac macrophages, immune cells pivotal for tissue health maintenance but prone to inflammation in response to injury such as heart attack or heart failure. Analyzing heart tissue specimens from deceased COVID-19 patients with ARDS and comparing them with non-COVID-19 deceased individuals, alongside infecting mice with SARS-CoV-2, the team uncovered a surge in the total number of cardiac macrophages and a transformation towards an inflammatory state induced by SARS-CoV-2 infection.

Furthermore, through experiments in mice simulating lung inflammation signals without actual virus presence, the researchers replicated the shift in heart macrophages observed in COVID-19 patients and infected mice. This demonstrated that severe lung infection alone could incite inflammatory responses in heart macrophages, emphasizing the broader implications beyond direct viral effects.

Moreover, the team discovered that neutralizing antibodies could halt the influx of inflammatory cardiac macrophages in mice, preserving cardiac function. While yet to be tested in humans, such interventions could potentially serve as preventive measures for COVID-19 patients with pre-existing conditions or individuals at higher risk of severe outcomes from SARS-CoV-2-associated ARDS.